The work, reported by Huang, Jiang, Gao and colleagues in Nature Sensors, is based on an artificial retina made from indium nitride, or InNₓ, waveguide-coupled photodetectors. The researchers took inspiration from the human eye, where the retina is not simply a flat sheet of independent light sensors. Instead, retinal cells are arranged in a layered, vertically organized structure that captures, filters and begins processing optical information before signals travel to the brain. The new device uses a comparable vertical one-dimensional pixel architecture, allowing light collection and signal conversion to take place in a compact stack rather than across a large lateral footprint.

At the heart of the system are pixels coupled to optical waveguides. A waveguide confines and directs light, much like a microscopic channel for photons. In this artificial retina, waveguide coupling helps guide incoming light toward the active InNₓ photodetection regions, improving the interaction between the optical field and the semiconductor material. This arrangement can increase the effective absorption of light while allowing individual pixels to occupy less surface area. By moving part of the optical path into the vertical dimension, the architecture addresses a fundamental trade-off in conventional image sensors: smaller pixels often collect fewer photons, while larger pixels limit resolution and integration density.

The reported artificial retina contains 7.84 million pixels per square centimetre, equivalent to approximately 7,000 pixels per inch. That density is about an order of magnitude higher than the density of photoreceptors in the human retina, according to the researchers. High pixel density is important for robotic vision because it can improve the detection of fine edges, small objects and rapid changes in a scene. Yet density alone does not guarantee useful imaging. Tiny pixels can suffer from weak signals, optical crosstalk and increased noise. The waveguide-coupled design is intended to preserve light-collection efficiency even as the pixels shrink, while the flexible substrate allows the retina to conform to curved optical surfaces.

The device also achieved a reported specific detectivity of 2.17 × 10¹⁴ jones, a figure used to describe how effectively a photodetector can distinguish weak optical signals from background noise. In practical terms, high detectivity means that the sensor can respond to very low levels of illumination without being overwhelmed by dark current or electronic fluctuations. This capability could be valuable in applications where artificial eyes must operate across changing conditions, from bright outdoor environments to dim indoor scenes. The reported performance suggests that the InNₓ photodetectors can combine miniaturization with a strong electrical response, although real-world operation will also depend on system-level factors such as calibration, temperature stability and optical alignment.

The researchers integrated the retina into a bionic-eye platform with a tunable depth of field. Depth of field describes the range of distances that appear acceptably sharp in an image. Human eyes alter their focus by changing the shape of the lens, but many artificial vision systems rely on fixed optics or mechanical focusing elements. A depth-tunable bionic eye can instead adapt its imaging configuration to objects at different distances. In the reported demonstrations, this capability supported three-dimensional spatial imaging and motion tracking, allowing the system to gather information not only about where objects appear in a scene, but also about their relative depth and movement.

The optical system was further equipped with coordinated aberration compensation. Aberrations are imperfections introduced when lenses or curved imaging surfaces fail to bring all light rays to the same ideal focus. They can blur details, distort shapes and reduce image quality, particularly near the edges of a wide field of view. The researchers report that their approach produced a 110-degree field of view while reducing field curvature by 45.7%. Field curvature causes a flat scene to project onto a curved focal surface, meaning that an image cannot remain uniformly sharp from centre to edge. Correcting this effect is essential for a bionic eye intended to operate in dynamic environments, where important information may appear anywhere within a broad visual field.

The system’s most ambitious feature is that some visual processing takes place inside the sensor rather than being sent entirely to an external processor. This approach, known as in-sensor processing, can reduce the amount of raw data that must be transferred and analysed by a separate computer. Conventional cameras may generate enormous streams of pixel data, creating delays and consuming significant energy when every frame must be transmitted for interpretation. By performing functions such as signal conditioning, denoising or feature extraction at the point of image capture, a neuromorphic sensor can respond more efficiently to events. The researchers demonstrated denoising-based recognition, suggesting that the device can suppress unwanted fluctuations while retaining visual features needed for identifying objects or patterns.

In motion experiments, dynamic focus adaptation helped the bionic eye reconstruct trajectories with a reported accuracy of 96.1%. The result points toward applications in autonomous robots, wearable devices, intelligent cameras and machines that must react to moving objects in real time. A robot equipped with such a vision system could potentially track a fast-moving target while adjusting focus and compensating for optical distortion, rather than relying on multiple cameras or computationally intensive corrections after image capture. The system’s combination of dense sensing, depth awareness, wide-angle imaging and local processing is particularly relevant to embodied intelligence, in which machines must interpret their surroundings while physically interacting with them.

The researchers describe the artificial retina as a step toward vision systems that more closely resemble the integrated operation of biological eyes and brains. Its vertical pixel architecture addresses the physical challenge of packing large numbers of sensitive detectors into a small, flexible area, while waveguide coupling helps preserve optical efficiency at the pixel scale. Tunable depth of field and aberration compensation extend the system beyond basic image capture, giving it the ability to adapt to different distances and maintain image quality across a broad view. Further development will be needed to assess durability, manufacturing scalability, power consumption and performance outside controlled demonstrations. Even so, the work offers a striking glimpse of how future machines might see: not through a camera that merely records images, but through a responsive artificial retina that focuses, filters, interprets and acts on visual information as it arrives.

Subject of Research: Flexible neuromorphic artificial retina and bionic-eye vision system using ultradense InNₓ waveguide-coupled photodetectors for tunable-depth 3D imaging, motion tracking and in-sensor processing.

Article Title: A neuromorphic bionic eye with ultradense waveguide-coupled pixels for depth-tunable 3D vision

Article References: Huang, PY., Jiang, B., Gao, JS. et al. “A neuromorphic bionic eye with ultradense waveguide-coupled pixels for depth-tunable 3D vision.” Nature Sensors (2026). https://doi.org/10.1038/s44460-026-00119-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44460-026-00119-y

Keywords: neuromorphic vision, bionic eye, artificial retina, InNₓ photodetectors, waveguide-coupled pixels, 3D imaging, depth of field, motion tracking, in-sensor processing, embodied intelligence

In a groundbreaking development, a collaborative research team spearheaded by Professor Dong-Woo Cho from POSTECH’s Department of Mechanical Engineering, alongside Professor Jae Yon Won from Eunpyeong St. Mary’s Hospital’s Department of Ophthalmology and Visual Science, and Professor Joeng Ju Kim of the Department of Bioscience and Biotechnology at Hankuk University of Foreign Studies, has engineered a revolutionary retinal vein occlusion disease model. This model is built on a sophisticated retina-on-a-chip platform that integrates advanced 3D bioprinting technology with a novel hybrid retinal decellularized extracellular matrix (RdECM) bioink. Published in the prestigious journal Advanced Composites and Hybrid Materials, this study represents a significant leap forward in recapitulating the pathological microenvironment of RVO in vitro, providing a powerful tool to decode disease mechanisms and test therapeutic interventions.

The core innovation underlying this platform is the utilization of an integrated 3D bioprinting system that fabricates complex retinal tissue architectures incorporating both vascular and neural components. The hybrid RdECM bioink, derived from naturally decellularized retinal tissues, retains key biochemical cues essential for cellular physiologic behavior and tissue-specific microenvironments. By bioprinting this composite bioink into microfluidic chips, the researchers have successfully recreated a layered retina structure featuring endothelial-lined vasculature adjacent to neural retinal cells. Within this microengineered retina-on-a-chip, the team induced vascular occlusion events, mirroring the pathological blockages characteristic of RVO. This approach enabled the real-time observation of hallmark disease phenomena, including inflammatory responses, blood-retinal barrier dysfunction, and aberrant angiogenic processes.

One of the most striking outcomes of this model is its ability to faithfully reproduce the vascular leakage and edema extensively documented in clinical RVO cases. The bioprinted retinal vessels in the chip model displayed compromised selective permeability, reflecting the breakdown of endothelial junctions pivotal to maintaining retinal homeostasis in vivo. This barrier disruption facilitated direct visualization of edema and immune cell infiltration dynamics, offering unprecedented insights into the cross-talk between vascular endothelial cells and adjacent retinal neurons during RVO progression. The fidelity with which this system recapitulates human RVO pathology opens new avenues for investigating molecular mechanisms driving disease initiation and progression.

Beyond disease modeling, the retina-on-a-chip platform demonstrated remarkable utility in pharmacological testing. When exposed to standard-of-care drugs commonly employed for RVO management, the model exhibited drug response profiles aligning closely with clinical outcomes. For instance, aspirin administration effectively mitigated vascular endothelial damage, attenuating the extent of leakage and inflammation. Immunomodulatory treatment with dexamethasone reduced inflammatory signaling and tissue edema, while bevacizumab—a monoclonal antibody targeting VEGF—successfully suppressed abnormal neovascular proliferation. These congruent in vitro and clinical drug responses validate the platform’s potential as a preclinical assay system that bridges the gap between bench and bedside, enabling accurate evaluation of drug efficacy and safety.

This innovative approach reaffirms the power of organ-specific decellularized extracellular matrix bioinks in faithfully reproducing the intricate human tissue microenvironments needed for accurate disease modeling. The retinal dECM bioink not only provides a structural scaffold but also delivers essential biochemical and mechanical cues that drive cell differentiation, survival, and function, replicating the native retinal milieu. Such biomimicry is critical for developing meaningful organ-on-a-chip systems capable of mimicking the unique physiology of human tissues, thereby improving predictive accuracy in drug development and personalized medicine applications.

In addition to its pharmaceutical screening capabilities, the retina-on-a-chip RVO model heralds a new direction for mechanistic studies into retinal vascular biology and pathology. It offers a controlled platform to dissect the molecular pathways activated by venous occlusion, elucidate endothelial-neuronal interactions, and explore inflammatory and immune responses within the retinal tissue context. This granular understanding may reveal novel therapeutic targets and biomarkers, facilitating the design of next-generation interventions for retinal diseases.

An important facet of this bioengineered model is its potential to significantly reduce reliance on animal experimentation. Conventional in vivo RVO models, while informative, often suffer from species-specific differences that limit translational relevance. The human cell-based retina-on-a-chip circumvents these limitations, offering an ethically favorable, reproducible, and scalable system that enhances the fidelity of experimental outcomes. This aligns with ongoing efforts in biomedical research to embrace alternative methodologies that reduce animal use without compromising scientific rigor.

The convergence of mechanical engineering, ophthalmology, and biotechnology exemplified in this study underscores the multidisciplinary nature essential to advancing regenerative medicine and tissue engineering. The seamless integration of 3D bioprinting technology with biomaterial science and clinical ophthalmology is a testament to the collaborative spirit driving innovation in healthcare. Such cross-sector partnerships are pivotal for transforming laboratory discoveries into practical clinical solutions.

Looking forward, the research team envisions adapting this platform for personalized medicine applications by incorporating patient-derived cells to generate customized RVO models tailored to individual pathological characteristics. This approach could revolutionize disease monitoring and treatment selection, enabling the identification of optimal therapeutic regimens for specific patient profiles. Moreover, the platform’s modular design may facilitate modeling a range of retinal diseases beyond RVO, expanding its impact within the ophthalmic research community.

This pioneering work was made possible through robust support from the Alchemist Project of Korea’s Ministry of Trade, Industry and Energy, the National Program for Regenerative Medicine, the Young Researcher Program of the National Research Foundation of Korea, and funding from Hankuk University of Foreign Studies. Such investment highlights the strategic importance of advancing biomedical engineering research to address pressing healthcare challenges like vision loss and retinal diseases.

In sum, the development of this 3D cell-printed RVO model via an advanced retina-on-a-chip platform represents a milestone in ophthalmic disease modeling. The system’s high physiological relevance, ability to replicate complex disease phenotypes, and accurate predictive responses to therapeutics present transformative opportunities for accelerating drug development, elucidating disease mechanisms, and ultimately preserving vision for millions worldwide. As organ-on-a-chip technologies continue to evolve, innovations like this herald a future where patient-specific, biomimetic disease models become routine tools in personalized healthcare.

Subject of Research: Development of an advanced retina-on-a-chip model for retinal vein occlusion using 3D bioprinting and hybrid retinal decellularized extracellular matrix bioink.

Article Title: Development of a 3D cell-printed RVO model by advancing a retina-on-a-chip with hybrid retinal dECM bioink and an integrated 3D bioprinting system

News Publication Date: 1-Oct-2025

Web References:
DOI: 10.1007/s42114-025-01455-2

Image Credits: POSTECH

Keywords: Health and medicine, Biomedical engineering, Diseases and disorders, Vision disorders, Retinopathy, Cell structure, Extracellular matrix, Mechanical engineering, Materials engineering, Biomaterials, Physiology, Vascular biology